patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the … biotherapeutics tocilizumab, siltuximab and sarilumab. … support national patent offices and interested parties in developing countries with information that can serve as guidance for …

The World Health Organization (WHO) should act as the directing and coordinating authority in global health but it has … contributions and consequent impoverishment, and the proliferation of "new" international health agencies to which WHO has been … actors in global health, and leads to the neglect of health as a development issue. Today the global health system is more …